BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20461043)

  • 1. The role of hematopoietic stem-cell transplantation in cutaneous T-cell lymphoma.
    Hoff NP; Bruch-Gerharz D
    G Ital Dermatol Venereol; 2010 Jun; 145(3):345-59. PubMed ID: 20461043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on treatment of cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
    Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
    Duarte RF; Schmitz N; Servitje O; Sureda A
    Bone Marrow Transplant; 2008 Apr; 41(7):597-604. PubMed ID: 18176611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Duarte RF; Canals C; Onida F; Gabriel IH; Arranz R; Arcese W; Ferrant A; Kobbe G; Narni F; Deliliers GL; Olavarría E; Schmitz N; Sureda A
    J Clin Oncol; 2010 Oct; 28(29):4492-9. PubMed ID: 20697072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides.
    Molina A; Zain J; Arber DA; Angelopolou M; O'Donnell M; Murata-Collins J; Forman SJ; Nademanee A
    J Clin Oncol; 2005 Sep; 23(25):6163-71. PubMed ID: 16135483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell transplantation in advanced cutaneous T-cell lymphoma.
    Introcaso CE; Leber B; Greene K; Ubriani R; Rook AH; Kim EJ
    J Am Acad Dermatol; 2008 Apr; 58(4):645-9. PubMed ID: 18258335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Cutaneous T-Cell Lymphomas.
    Larocca CA; LeBoeuf NR
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma.
    Gibson JF; Alpdogan O; Subtil A; Girardi M; Wilson LD; Roberts K; Foss F
    J Am Acad Dermatol; 2015 Jun; 72(6):1010-5.e5. PubMed ID: 25981001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.
    Virmani P; Zain J; Rosen ST; Myskowski PL; Querfeld C
    Dermatol Clin; 2015 Oct; 33(4):807-18. PubMed ID: 26433851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
    Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
    Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.